Self-injectable drugs help patients manage chronic conditions from the convenience of home, yet they’re more complicated to administer than oral drugs, creating barriers for patients to initiate and stay on therapy. Patients with a chronic inflammatory disease can encounter obstacles throughout the care journey—from poor health and low literacy before the diagnosis, to anxiety about the injection process once they receive a RX, to lack of motivation and side effects concerns throughout their therapy.
Download the case study PDF to read more
CareMetx : Nov 18, 2022 8:00:00 AM
A leading pharmaceutical manufacturer partnered with CareMetx to improve initiation rates and time on therapy for a self-injected...
CareMetx : Mar 25, 2022 3:19:00 PM
This manufacturer of a leading office-based injectable sought an automated, cost-effective way to tackle those administrative burdens to help ensure...
CareMetx : Feb 16, 2024 11:52:38 AM
CareMetx leveraged specialized patient support services to help navigate the hurdles associated with biosimilar products. By employing these...
CareMetx